Company Overview - Sino Medical Science Technology Co., Ltd. is located in Tianjin Economic-Technological Development Area and was established on September 21, 2007. The company went public on October 30, 2019. Its main business involves the research, production, and sales of high-end interventional medical devices, focusing on cardiovascular, cerebrovascular, and structural heart disease treatment areas [1]. Financial Performance - As of June 30, the number of shareholders for Sino Medical increased to 11,100, a rise of 0.42% from the previous period. The average circulating shares per person increased by 0.21% to 37,515 shares [2]. - For the first half of 2025, Sino Medical reported a revenue of 240 million yuan, representing a year-on-year growth of 12.53%. The net profit attributable to shareholders was 13.84 million yuan, showing a significant increase of 296.54% year-on-year [2]. Stock Performance - On September 9, Sino Medical's stock price rose by 2.06%, reaching 33.17 yuan per share, with a trading volume of 235 million yuan and a turnover rate of 1.71%. The total market capitalization stood at 13.8 billion yuan [1]. - Year-to-date, Sino Medical's stock price has increased by 239.86%. In the last five trading days, the stock rose by 3.01%, while it gained 32.10% over the past 20 days and 202.65% over the last 60 days [1]. - The company has appeared on the daily trading leaderboard six times this year, with the most recent occurrence on August 22 [1]. Revenue Composition - The revenue composition of Sino Medical is as follows: stents account for 59.76%, balloons for 32.68%, and other products for 7.56% [1]. Dividend Information - Since its A-share listing, Sino Medical has distributed a total of 41 million yuan in dividends. However, there have been no dividend distributions in the past three years [3].
赛诺医疗涨2.06%,成交额2.35亿元,主力资金净流入717.82万元